tumor antigen-pulsed DC vaccine
/ Sichuan University
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 07, 2022
A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC
(clinicaltrials.gov)
- P1 | N=20 | Not yet recruiting | Sponsor: Sichuan University
New P1 trial • Esophageal Cancer • Esophageal Squamous Cell Carcinoma • Oncology
1 to 1
Of
1
Go to page
1